http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210098379-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f4e27efe063c6cfdc546cebc6ac6b78 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2871 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-8831 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2560-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-7233 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9bf8883ff1185e0e0fb021daec887c6 |
| publicationDate | 2021-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20210098379-A |
| titleOfInvention | Composition comprising metabolic biomarkers for diagnosis of stroke |
| abstract | The present invention relates to a biomarker composition for diagnosis of stroke, and specifically, 3-Methoxytyramine, homocysteine sulfinic acid, carnitine, tryptophan, and sphing A biomarker composition for diagnosis of stroke comprising at least one selected from the group consisting of Sphingosine as an active ingredient; a composition for diagnosing stroke comprising an agent capable of measuring the biomarker level; a kit for diagnosing stroke comprising the composition for diagnosing stroke; And it relates to a method for providing information for the diagnosis of stroke. It was confirmed that the biomarker for stroke diagnosis according to the present invention was highly expressed in the stroke risk group. This means that the diagnosis of a high-risk group and the possibility of onset can be predicted by using the biomarker for diagnosis of stroke of the present invention, which can be usefully utilized in the fields of stroke prevention, diagnosis and treatment. |
| priorityDate | 2020-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.